MedTrace Logo

Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk

NCT01717677 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 457

Last updated 2021-02-10

No results posted yet for this study

Summary

4arms preference based Study to compare four therapy options in prostate cancer with low or early intermediate risk

Conditions

Interventions

PROCEDURE

radical prostatectomy

RADIATION

percutaneous radiation therapy

RADIATION

permanent seed implantation

PROCEDURE

Active Surveillance

Sponsors & Collaborators

  • Association of Urologic Oncology (AUO)

    lead OTHER

Principal Investigators

  • Michael Stöckle, Prof. Dr. · Klinik für Urologie und Kinderurologie der Universität des Saarlandes

  • Thomas Wiegel, Prof. Dr. · Klinik für Strahlentherapie und Radioonkologie der Universität Ulm

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-01-31
Completion
2018-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01717677 on ClinicalTrials.gov